We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-4.45%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.08B
AUM Growth
+$322M
Cap. Flow
+$648M
Cap. Flow %
21%
Top 10 Hldgs %
37.4%
Holding
321
New
89
Increased
78
Reduced
45
Closed
96

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$32M
2
CCCC icon
C4 Therapeutics
CCCC
+$14.5M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$14.1M
4
AMRS
Amyris Inc.
AMRS
+$11M
5
TECH icon
Bio-Techne
TECH
+$10.3M

Top Sells

Rank Stock Value
1
NTRA icon
Natera
NTRA
+$14.1M
2
DXCM icon
DexCom
DXCM
+$14.1M
3
ICUI icon
ICU Medical
ICUI
+$14M
4
LIVN icon
LivaNova
LIVN
+$12.2M
5
OLPX
Olaplex Holdings
OLPX
+$11.6M

Sector Composition

Rank Sector Weight
1 Healthcare 24.06%
2 Materials 0.35%
3 Industrials 0.17%
4 Consumer Discretionary 0.07%
5 Financials 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMRS
76
DELISTED
Amyris Inc.
AMRS
$10.7M 0.35%
+2,461,436
New +$11M
OLK
77
CALL
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$10.4M 0.34%
590,000
+179,600
+44% +$2.93M
APLS
78
CALL
DELISTED
Apellis Pharmaceuticals
APLS
$10.2M 0.33%
+200,000
New +$8.83M
QTRX icon
79
CALL
Quanterix
QTRX
$139M
$10.1M 0.33%
+344,600
New +$10.5M
A icon
80
PUT
Agilent Technologies
A
$41.9B
$9.93M 0.32%
+75,000
New +$10.3M
VRAY
81
CALL
DELISTED
ViewRay, Inc.
VRAY
$9.8M 0.32%
2,500,000
+1,317,200
+111% +$5.61M
CDXS icon
82
Codexis
CDXS
$172M
$9.61M 0.31%
465,902
+2,800
+0.6% +$58K
XLB icon
83
PUT
State Street Materials Select Sector SPDR ETF
XLB
$8.61B
$9.49M 0.31%
+250,000
New +$10.7M
EXAS
84
CALL
DELISTED
Exact Sciences
EXAS
$9.44M 0.31%
+135,000
New +$9.87M
INSP icon
85
CALL
Inspire Medical Systems
INSP
$1.68B
$8.98M 0.29%
35,000
+15,300
+78% +$3.5M
ISEE
86
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$8.91M 0.29%
529,600
+301,500
+132% +$4.46M
SKIN icon
87
CALL
SkinHealth Systems
SKIN
$84.2M
$8.85M 0.29%
+524,100
New +$8.65M
MRNA icon
88
CALL
Moderna
MRNA
$25.4B
$8.61M 0.28%
+50,000
New +$8.42M
GH icon
89
PUT
Guardant Health
GH
$22.2B
$8.61M 0.28%
+130,000
New +$8.9M
THC icon
90
CALL
Tenet Healthcare
THC
$21.5B
$8.17M 0.26%
95,000
-131,700
-58% -$10.8M
ALNY icon
91
PUT
Alnylam Pharmaceuticals
ALNY
$30B
$8.16M 0.26%
+50,000
New +$7.62M
PRVA icon
92
CALL
Privia Health
PRVA
$2.75B
$8.02M 0.26%
+300,000
New +$7.08M
IART icon
93
PUT
Integra LifeSciences
IART
$1.35B
$7.96M 0.26%
123,900
+700
+0.6% +$46.1K
BVS icon
94
Bioventus
BVS
$1.17B
$7.84M 0.25%
555,910
+3,700
+0.7% +$49.5K
IMUX icon
95
Immunic
IMUX
$217M
$7.72M 0.25%
+68,329
New +$7.91M
NTLA icon
96
Intellia Therapeutics
NTLA
$1.69B
$7.56M 0.25%
104,073
+50,144
+93% +$4.25M
WBA
97
CALL
DELISTED
Walgreens Boots Alliance
WBA
$7.16M 0.23%
+160,000
New +$7.87M
AZTA icon
98
PUT
Azenta
AZTA
$1.47B
$7M 0.23%
+84,500
New +$7.25M
EXAS
99
PUT
DELISTED
Exact Sciences
EXAS
$6.99M 0.23%
100,000
-25,000
-20% -$1.83M
LMAT icon
100
PUT
LeMaitre Vascular
LMAT
$1.88B
$6.89M 0.22%
148,200
-58,600
-28% -$2.62M
2 3
4
5 6

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2022 Portfolio in Review

As of Q1 2022, Pura Vida Investments held 321 positions worth $3.08B, up 12% from $2.76B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Pura Vida Investments deployed $648M of net new capital in Q1 2022, opening 89 new positions and adding to 78 existing holdings. Its largest new stake was Biogen: 147,135 shares worth $31M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 30% a quarter earlier, followed by Materials and Industrials.

On the sell side, the largest reduction was ICU Medical, an estimated $14M trimmed.

  • Pura Vida Investments's largest Q1 2022 buy was Biogen: 147,135 shares worth $31M.
  • Pura Vida Investments added most to C4 Therapeutics in Q1 2022, an estimated $14.5M increase.
  • Pura Vida Investments's biggest Q1 2022 reduction was ICU Medical, cutting an estimated $14M.
  • Pura Vida Investments fully exited Natera in Q1 2022, selling an estimated $14.1M.
  • Pura Vida Investments's ten largest holdings make up 37% of its $3.08B portfolio in Q1 2022.
  • Pura Vida Investments opened 89 new positions and closed 96 in Q1 2022.
  • Pura Vida Investments's portfolio value rose 12% quarter-over-quarter to $3.08B.

Based on Pura Vida Investments's 13F filing for Q1 2022, filed 16 May 2022.